Amoebic Deoxyribonucleic Acid (DNA) (Amoebic DNA)

Amoebic Deoxyribonucleic Acid (DNA) is the primary genetic material of parasitic protozoa, most notably Entamoeba histolytica, which causes amoebiasis in humans. It serves as the essential blueprint for the parasite's replication and survival within the anaerobic environment of the human colon and extraintestinal sites like the liver (CDC, 2022). Amoebic DNA is a critical therapeutic target for the nitroimidazole class of antibiotics, including metronidazole and tinidazole. These drugs are activated within the parasite to form cytotoxic radicals that induce extensive DNA strand breakage and destabilize the double helix. This mechanism effectively halts DNA synthesis and leads to rapid cell death of the trophozoites. Targeting amoebic DNA is the standard of care for treating invasive amoebic dysentery and preventing complications such as amoebic liver abscesses (NIH, 2023). Furthermore, the detection of specific amoebic DNA sequences via PCR is the gold standard for distinguishing pathogenic E. histolytica from non-pathogenic species like E. dispar.

Other names

Entamoeba histolytica DNAProtozoal DNAAmebic DNAParasitic DNA

Nitroimidazole drugs act as prodrugs that are selectively reduced by the anaerobic metabolic pathways of the amoeba, specifically via the enzyme pyruvate:ferredoxin oxidoreductase (PFOR). This reduction generates highly reactive nitro-radical intermediates that cause covalent binding to the amoebic DNA, leading to helical structure disruption, strand breakage, and the subsequent inhibition of nucleic acid synthesis (StatPearls, 2023; PubMed: 10511373).